监测在肝细胞癌预防中的作用。
Role of surveillance in prevention of hepatocellular carcinoma.
作者信息
Panda Dipanjan
机构信息
Department of Medical Oncology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi 110014, India.
出版信息
J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S43-9. doi: 10.1016/j.jceh.2014.03.044. Epub 2014 May 25.
Abstract
Hepatocellular carcinoma is a common malignancy and one of the important public health problems in India. The surveillance of hepatocellular carcinoma (HCC) is an established approach to detect early cancers in patients with defined risks. However, there are still controversies and issues to be addressed regarding the optimal surveillance methods and interval. The current level of awareness among physicians in India about surveillance is low and the need and most cost effective surveillance strategy in developing country like ours is unclear. This article has tried to discuss these issues in their appropriate perspective. To address this complicated issue, a multicenter randomized prospective study however may be required.
摘要
肝细胞癌是一种常见的恶性肿瘤，也是印度重要的公共卫生问题之一。肝细胞癌（HCC）的监测是在具有明确风险的患者中检测早期癌症的既定方法。然而，关于最佳监测方法和间隔时间仍存在争议和问题有待解决。印度医生目前对监测的认识水平较低，在像我们这样的发展中国家，需求和最具成本效益的监测策略尚不清楚。本文试图从适当的角度讨论这些问题。然而，为了解决这个复杂的问题，可能需要进行一项多中心随机前瞻性研究。
相似文献
1
Role of surveillance in prevention of hepatocellular carcinoma.监测在肝细胞癌预防中的作用。
J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S43-9. doi: 10.1016/j.jceh.2014.03.044. Epub 2014 May 25.
2
Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.术前甲胎蛋白和脱γ-羧基凝血酶原在肝细胞癌患者中的预后作用
World J Gastroenterol. 2015 Apr 28;21(16):4933-45. doi: 10.3748/wjg.v21.i16.4933.
3
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis.GALAD 评分可在国际非酒精性脂肪性肝炎患者队列中早期检测肝细胞癌。
Clin Gastroenterol Hepatol. 2020 Mar;18(3):728-735.e4. doi: 10.1016/j.cgh.2019.11.012. Epub 2019 Nov 8.
4
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.肝细胞癌肝硬化监测：系统评价与经济分析
Health Technol Assess. 2007 Sep;11(34):1-206. doi: 10.3310/hta11340.
5
Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.在中国，去γ-羧基凝血酶原与甲胎蛋白对乙型肝炎病毒相关肝细胞癌的诊断评估：一项大规模、多中心研究
PLoS One. 2016 Apr 12;11(4):e0153227. doi: 10.1371/journal.pone.0153227. eCollection 2016.
6
Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis.现实环境中肝细胞癌病因变化及非移植性根治性治疗方式的经验——一项回顾性描述性分析
J Clin Exp Hepatol. 2021 Nov-Dec;11(6):682-690. doi: 10.1016/j.jceh.2021.02.002. Epub 2021 Feb 11.
7
GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients.GALAD评分在欧洲慢性乙型和丙型肝炎患者队列中可检测早期肝细胞癌
Pharmaceuticals (Basel). 2021 Jul 27;14(8):735. doi: 10.3390/ph14080735.
8
Refinement and validation of a comprehensive clinical diagnostic model (GAMAD) based on gender, age, multitarget circulating tumour DNA methylation signature and commonly used serological biomarkers for early detection of hepatocellular carcinoma: a multicentre, prospective observational study protocol.基于性别、年龄、多靶点循环肿瘤 DNA 甲基化特征和常用血清学生物标志物的综合临床诊断模型（GAMAD）的优化和验证用于早期检测肝细胞癌：一项多中心、前瞻性观察研究方案。
BMJ Open. 2023 Sep 18;13(9):e076467. doi: 10.1136/bmjopen-2023-076467.
9
A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk.肝癌高危患者筛查实用指南
Mayo Clin Proc Innov Qual Outcomes. 2019 Jul 11;3(3):302-310. doi: 10.1016/j.mayocpiqo.2019.04.005. eCollection 2019 Sep.
10
Epidemiology and surveillance of hepatocellular carcinoma.肝细胞癌的流行病学与监测
Liver Cancer. 2012 Jun;1(1):2-14. doi: 10.1159/000339016.
引用本文的文献
1
Construction of a Novel Cuproptosis-Related ceRNA Network-SNHG3/miR-1306-5p/PDHA1 and Identification of SNHG3 as a Prognostic Biomarker in Hepatocellular Carcinoma.新型铜死亡相关ceRNA网络-SNHG3/miR-1306-5p/PDHA1的构建及SNHG3作为肝细胞癌预后生物标志物的鉴定
ACS Omega. 2023 Oct 3;8(41):38690-38703. doi: 10.1021/acsomega.3c06018. eCollection 2023 Oct 17.
2
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.印度肝脏研究全国协会关于印度肝细胞癌预防、诊断和管理的共识2019年更新：普里II建议
J Clin Exp Hepatol. 2020 Jan-Feb;10(1):43-80. doi: 10.1016/j.jceh.2019.09.007. Epub 2019 Sep 23.
3
Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.非酒精性脂肪性肝病相关肝细胞癌：日益受到关注。
Indian J Med Res. 2019 Jan;149(1):9-17. doi: 10.4103/ijmr.IJMR_1456_17.
4
Hepatobiliary quiz-12 (2014).肝胆知识问答 - 12（2014年）
J Clin Exp Hepatol. 2014 Dec;4(4):376-9. doi: 10.1016/j.jceh.2014.11.004.
本文引用的文献
1
Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?在 HALT-C 试验中，晚期肝细胞癌患者的检测：监测在哪里失败了？
Am J Gastroenterol. 2013 Mar;108(3):425-32. doi: 10.1038/ajg.2012.449. Epub 2013 Jan 22.
2
Quality improvement measures lead to higher surveillance rates for hepatocellular carcinoma in patients with cirrhosis.质量改进措施可提高肝硬化患者肝细胞癌的监测率。
Dig Dis Sci. 2013 Apr;58(4):1157-60. doi: 10.1007/s10620-012-2461-4. Epub 2012 Nov 1.
3
Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.肝细胞癌：ESMO-ESDO诊断、治疗及随访临床实践指南
Ann Oncol. 2012 Oct;23 Suppl 7:vii41-8. doi: 10.1093/annonc/mds225.
4
Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India.亚洲印度人的代谢综合征患病率及危险因素：一项来自印度东部城市的社区研究。
J Cardiovasc Dis Res. 2012 Jul;3(3):204-11. doi: 10.4103/0975-3583.98895.
5
Failure rates in the hepatocellular carcinoma surveillance process.肝癌监测过程中的失败率。
Cancer Prev Res (Phila). 2012 Sep;5(9):1124-30. doi: 10.1158/1940-6207.CAPR-12-0046. Epub 2012 Jul 30.
6
Hepatocellular carcinoma: cost-effectiveness of screening. A systematic review.肝细胞癌：筛查的成本效益。系统评价。
Risk Manag Healthc Policy. 2012;5:49-54. doi: 10.2147/RMHP.S18677. Epub 2012 Jun 19.
7
Cancer mortality in India: a nationally representative survey.印度的癌症死亡率：一项全国代表性调查。
Lancet. 2012 May 12;379(9828):1807-16. doi: 10.1016/S0140-6736(12)60358-4. Epub 2012 Mar 28.
8
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.欧洲肝脏研究学会-欧洲肿瘤内科学会临床实践指南：肝细胞癌的管理
J Hepatol. 2012 Apr;56(4):908-43. doi: 10.1016/j.jhep.2011.12.001.
9
Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis.肝硬化患者肝癌监测的效果。
Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):793-9. doi: 10.1158/1055-9965.EPI-11-1005. Epub 2012 Feb 28.
10
Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review.美国患者肝癌监测的利用情况：系统评价。
J Gen Intern Med. 2012 Jul;27(7):861-7. doi: 10.1007/s11606-011-1952-x. Epub 2012 Jan 4.
Zotero 插件